For example, the anti-TNF-α antibodies infliximab [8], adalimumab [9], golimumab [10] and certolizumab [11] are commonly used in clinical practice for the treatment of patients with rheumatoid arthritis. The gene discussed is TNF; the disease is rheumatoid arthritis.